Selective inhibition of TNFR1 reduces osteoclast numbers and is differentiated from anti-TNF in a LPS-driven model of inflammatory bone loss
Espirito Santo, A.I., Ersek, A., Freidin, A., Feldmann, M., Stoop, A.A., Horwood, N.J.Volume:
464
Language:
english
Journal:
Biochemical and Biophysical Research Communications
DOI:
10.1016/j.bbrc.2015.07.094
Date:
September, 2015
File:
PDF, 1.14 MB
english, 2015